The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Next-Generation Wearable Holter Device Market Research Report 2024
Synopsis
A Holter monitor is a small, wearable device that records your heart activity for typically 24 to 72 hours, and up to 7 to 14 days. The device is small, lightweight, and hangs around your neck while connecting cable to sensors attached to your chest. A Holter monitor captures all your heart activity throughout the day and while your sleep. This allows a physician to determine if there are intermittent abnormalities to your heart rhythm over an extended period of time. The test is safe and painless.
Global Next-Generation Wearable Holter Device market is projected to reach US$ 1622.6 million in 2029, increasing from US$ 1200 million in 2022, with the CAGR of 3.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Next-Generation Wearable Holter Device market research.
Abnormal heartbeats are called arrhythmias. It causes a decrease in the heart's ability to pump blood, which reduces blood supply to vital organs such as the brain. Without proper blood flow to the brain, it can cause a person to faint, and when the rhythm returns to normal, the person regains consciousness. Therefore, heart rhythm is associated with many diseases and requires treatment. It is important to look for the cause of the rhythm disturbance and monitor electrical activity. This can be monitored with the help of an implantable heart monitor, which has a battery life of up to three or four years. The ICM continuously monitors heart rhythm and automatically stores records for years in real-world scenarios. With the capability of long-term continuous monitoring, ICM has proven to be a sensitive method for detecting unexplained syncope, subclinical atrial fibrillation and palpitations. These devices automatically record heart rate without any external intervention. The ICM can capture information that is often missed by a Holter or standard electrocardiogram (ECG), but some heart rhythm abnormalities occur rarely. Existing studies of these devices have provided sufficient evidence that implantable heart monitors are suitable for patients with atrial fibrillation, syncope and even myocardial infarction.
Atrial fibrillation is an irregular and often rapid heart rate that increases the risk of stroke, heart failure and other heart-related complications. It is expected to affect 17.9 million people by 2050. Short-term monitoring is not optimal for understanding the burden. After radiofrequency ablation, the ICM has become the first choice for cardiac monitoring. Fainting is a disorder triggered by a sudden, temporary drop in blood flow to the brain, resulting in loss of consciousness and muscle control. This is due to decreased blood flow to the brain or any other organ in the body. Low blood pressure can also cause passing out. The International Study of Syncope of Unknown Etiology (ISSUE) highlights various aspects of the utility of ICMs in the transient loss of consciousness (TLOC) population. It has been observed that ICM is used more in syncope than conventional testing. Myocardial infarction, commonly known as a heart attack, is said to occur when blood flow to the heart is blocked or completely stopped. The use of ICMs in patients with acute myocardial infarction allows for continuous ECG monitoring and a more detailed understanding of the incidence of bradyarrhythmias and tachyarrhythmias than conventional follow-up.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Next-Generation Wearable Holter Device market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Baxter
SmartCardia
AliveCor
iRhythm Technologies Inc
MediBioSense Ltd
Philips
LifeLabs
Aerotel Medical Systems
HeartBug
Wellue
Bardy Diagnostics
Coala Life
ScottCare
Biotricity
Cardiac Insight
Icentia Inc
Ranealth
Segment by Type
Chest Strap
ECG Patches
Segment by Application
E-commerce
Offline
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Next-Generation Wearable Holter Device report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
A Holter monitor is a small, wearable device that records your heart activity for typically 24 to 72 hours, and up to 7 to 14 days. The device is small, lightweight, and hangs around your neck while connecting cable to sensors attached to your chest. A Holter monitor captures all your heart activity throughout the day and while your sleep. This allows a physician to determine if there are intermittent abnormalities to your heart rhythm over an extended period of time. The test is safe and painless.
Global Next-Generation Wearable Holter Device market is projected to reach US$ 1622.6 million in 2029, increasing from US$ 1200 million in 2022, with the CAGR of 3.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Next-Generation Wearable Holter Device market research.
Abnormal heartbeats are called arrhythmias. It causes a decrease in the heart's ability to pump blood, which reduces blood supply to vital organs such as the brain. Without proper blood flow to the brain, it can cause a person to faint, and when the rhythm returns to normal, the person regains consciousness. Therefore, heart rhythm is associated with many diseases and requires treatment. It is important to look for the cause of the rhythm disturbance and monitor electrical activity. This can be monitored with the help of an implantable heart monitor, which has a battery life of up to three or four years. The ICM continuously monitors heart rhythm and automatically stores records for years in real-world scenarios. With the capability of long-term continuous monitoring, ICM has proven to be a sensitive method for detecting unexplained syncope, subclinical atrial fibrillation and palpitations. These devices automatically record heart rate without any external intervention. The ICM can capture information that is often missed by a Holter or standard electrocardiogram (ECG), but some heart rhythm abnormalities occur rarely. Existing studies of these devices have provided sufficient evidence that implantable heart monitors are suitable for patients with atrial fibrillation, syncope and even myocardial infarction.
Atrial fibrillation is an irregular and often rapid heart rate that increases the risk of stroke, heart failure and other heart-related complications. It is expected to affect 17.9 million people by 2050. Short-term monitoring is not optimal for understanding the burden. After radiofrequency ablation, the ICM has become the first choice for cardiac monitoring. Fainting is a disorder triggered by a sudden, temporary drop in blood flow to the brain, resulting in loss of consciousness and muscle control. This is due to decreased blood flow to the brain or any other organ in the body. Low blood pressure can also cause passing out. The International Study of Syncope of Unknown Etiology (ISSUE) highlights various aspects of the utility of ICMs in the transient loss of consciousness (TLOC) population. It has been observed that ICM is used more in syncope than conventional testing. Myocardial infarction, commonly known as a heart attack, is said to occur when blood flow to the heart is blocked or completely stopped. The use of ICMs in patients with acute myocardial infarction allows for continuous ECG monitoring and a more detailed understanding of the incidence of bradyarrhythmias and tachyarrhythmias than conventional follow-up.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Next-Generation Wearable Holter Device market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Baxter
SmartCardia
AliveCor
iRhythm Technologies Inc
MediBioSense Ltd
Philips
LifeLabs
Aerotel Medical Systems
HeartBug
Wellue
Bardy Diagnostics
Coala Life
ScottCare
Biotricity
Cardiac Insight
Icentia Inc
Ranealth
Segment by Type
Chest Strap
ECG Patches
Segment by Application
E-commerce
Offline
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Next-Generation Wearable Holter Device report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Next-Generation Wearable Holter Device Market Overview
1.1 Product Overview and Scope of Next-Generation Wearable Holter Device
1.2 Next-Generation Wearable Holter Device Segment by Type
1.2.1 Global Next-Generation Wearable Holter Device Market Value Comparison by Type (2023-2029)
1.2.2 Chest Strap
1.2.3 ECG Patches
1.3 Next-Generation Wearable Holter Device Segment by Application
1.3.1 Global Next-Generation Wearable Holter Device Market Value by Application: (2023-2029)
1.3.2 E-commerce
1.3.3 Offline
1.4 Global Next-Generation Wearable Holter Device Market Size Estimates and Forecasts
1.4.1 Global Next-Generation Wearable Holter Device Revenue 2018-2029
1.4.2 Global Next-Generation Wearable Holter Device Sales 2018-2029
1.4.3 Global Next-Generation Wearable Holter Device Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Next-Generation Wearable Holter Device Market Competition by Manufacturers
2.1 Global Next-Generation Wearable Holter Device Sales Market Share by Manufacturers (2018-2023)
2.2 Global Next-Generation Wearable Holter Device Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Next-Generation Wearable Holter Device Average Price by Manufacturers (2018-2023)
2.4 Global Next-Generation Wearable Holter Device Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Next-Generation Wearable Holter Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Next-Generation Wearable Holter Device, Product Type & Application
2.7 Next-Generation Wearable Holter Device Market Competitive Situation and Trends
2.7.1 Next-Generation Wearable Holter Device Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Next-Generation Wearable Holter Device Players Market Share by Revenue
2.7.3 Global Next-Generation Wearable Holter Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Next-Generation Wearable Holter Device Retrospective Market Scenario by Region
3.1 Global Next-Generation Wearable Holter Device Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Next-Generation Wearable Holter Device Global Next-Generation Wearable Holter Device Sales by Region: 2018-2029
3.2.1 Global Next-Generation Wearable Holter Device Sales by Region: 2018-2023
3.2.2 Global Next-Generation Wearable Holter Device Sales by Region: 2024-2029
3.3 Global Next-Generation Wearable Holter Device Global Next-Generation Wearable Holter Device Revenue by Region: 2018-2029
3.3.1 Global Next-Generation Wearable Holter Device Revenue by Region: 2018-2023
3.3.2 Global Next-Generation Wearable Holter Device Revenue by Region: 2024-2029
3.4 North America Next-Generation Wearable Holter Device Market Facts & Figures by Country
3.4.1 North America Next-Generation Wearable Holter Device Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Next-Generation Wearable Holter Device Sales by Country (2018-2029)
3.4.3 North America Next-Generation Wearable Holter Device Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Next-Generation Wearable Holter Device Market Facts & Figures by Country
3.5.1 Europe Next-Generation Wearable Holter Device Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Next-Generation Wearable Holter Device Sales by Country (2018-2029)
3.5.3 Europe Next-Generation Wearable Holter Device Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Next-Generation Wearable Holter Device Market Facts & Figures by Country
3.6.1 Asia Pacific Next-Generation Wearable Holter Device Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Next-Generation Wearable Holter Device Sales by Country (2018-2029)
3.6.3 Asia Pacific Next-Generation Wearable Holter Device Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Next-Generation Wearable Holter Device Market Facts & Figures by Country
3.7.1 Latin America Next-Generation Wearable Holter Device Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Next-Generation Wearable Holter Device Sales by Country (2018-2029)
3.7.3 Latin America Next-Generation Wearable Holter Device Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Next-Generation Wearable Holter Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Next-Generation Wearable Holter Device Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Next-Generation Wearable Holter Device Sales by Country (2018-2029)
3.8.3 Middle East and Africa Next-Generation Wearable Holter Device Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Next-Generation Wearable Holter Device Sales by Type (2018-2029)
4.1.1 Global Next-Generation Wearable Holter Device Sales by Type (2018-2023)
4.1.2 Global Next-Generation Wearable Holter Device Sales by Type (2024-2029)
4.1.3 Global Next-Generation Wearable Holter Device Sales Market Share by Type (2018-2029)
4.2 Global Next-Generation Wearable Holter Device Revenue by Type (2018-2029)
4.2.1 Global Next-Generation Wearable Holter Device Revenue by Type (2018-2023)
4.2.2 Global Next-Generation Wearable Holter Device Revenue by Type (2024-2029)
4.2.3 Global Next-Generation Wearable Holter Device Revenue Market Share by Type (2018-2029)
4.3 Global Next-Generation Wearable Holter Device Price by Type (2018-2029)
5 Segment by Application
5.1 Global Next-Generation Wearable Holter Device Sales by Application (2018-2029)
5.1.1 Global Next-Generation Wearable Holter Device Sales by Application (2018-2023)
5.1.2 Global Next-Generation Wearable Holter Device Sales by Application (2024-2029)
5.1.3 Global Next-Generation Wearable Holter Device Sales Market Share by Application (2018-2029)
5.2 Global Next-Generation Wearable Holter Device Revenue by Application (2018-2029)
5.2.1 Global Next-Generation Wearable Holter Device Revenue by Application (2018-2023)
5.2.2 Global Next-Generation Wearable Holter Device Revenue by Application (2024-2029)
5.2.3 Global Next-Generation Wearable Holter Device Revenue Market Share by Application (2018-2029)
5.3 Global Next-Generation Wearable Holter Device Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Corporation Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Next-Generation Wearable Holter Device Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Baxter Next-Generation Wearable Holter Device Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 SmartCardia
6.2.1 SmartCardia Corporation Information
6.2.2 SmartCardia Description and Business Overview
6.2.3 SmartCardia Next-Generation Wearable Holter Device Sales, Revenue and Gross Margin (2018-2023)
6.2.4 SmartCardia Next-Generation Wearable Holter Device Product Portfolio
6.2.5 SmartCardia Recent Developments/Updates
6.3 AliveCor
6.3.1 AliveCor Corporation Information
6.3.2 AliveCor Description and Business Overview
6.3.3 AliveCor Next-Generation Wearable Holter Device Sales, Revenue and Gross Margin (2018-2023)
6.3.4 AliveCor Next-Generation Wearable Holter Device Product Portfolio
6.3.5 AliveCor Recent Developments/Updates
6.4 iRhythm Technologies Inc
6.4.1 iRhythm Technologies Inc Corporation Information
6.4.2 iRhythm Technologies Inc Description and Business Overview
6.4.3 iRhythm Technologies Inc Next-Generation Wearable Holter Device Sales, Revenue and Gross Margin (2018-2023)
6.4.4 iRhythm Technologies Inc Next-Generation Wearable Holter Device Product Portfolio
6.4.5 iRhythm Technologies Inc Recent Developments/Updates
6.5 MediBioSense Ltd
6.5.1 MediBioSense Ltd Corporation Information
6.5.2 MediBioSense Ltd Description and Business Overview
6.5.3 MediBioSense Ltd Next-Generation Wearable Holter Device Sales, Revenue and Gross Margin (2018-2023)
6.5.4 MediBioSense Ltd Next-Generation Wearable Holter Device Product Portfolio
6.5.5 MediBioSense Ltd Recent Developments/Updates
6.6 Philips
6.6.1 Philips Corporation Information
6.6.2 Philips Description and Business Overview
6.6.3 Philips Next-Generation Wearable Holter Device Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Philips Next-Generation Wearable Holter Device Product Portfolio
6.6.5 Philips Recent Developments/Updates
6.7 LifeLabs
6.6.1 LifeLabs Corporation Information
6.6.2 LifeLabs Description and Business Overview
6.6.3 LifeLabs Next-Generation Wearable Holter Device Sales, Revenue and Gross Margin (2018-2023)
6.4.4 LifeLabs Next-Generation Wearable Holter Device Product Portfolio
6.7.5 LifeLabs Recent Developments/Updates
6.8 Aerotel Medical Systems
6.8.1 Aerotel Medical Systems Corporation Information
6.8.2 Aerotel Medical Systems Description and Business Overview
6.8.3 Aerotel Medical Systems Next-Generation Wearable Holter Device Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Aerotel Medical Systems Next-Generation Wearable Holter Device Product Portfolio
6.8.5 Aerotel Medical Systems Recent Developments/Updates
6.9 HeartBug
6.9.1 HeartBug Corporation Information
6.9.2 HeartBug Description and Business Overview
6.9.3 HeartBug Next-Generation Wearable Holter Device Sales, Revenue and Gross Margin (2018-2023)
6.9.4 HeartBug Next-Generation Wearable Holter Device Product Portfolio
6.9.5 HeartBug Recent Developments/Updates
6.10 Wellue
6.10.1 Wellue Corporation Information
6.10.2 Wellue Description and Business Overview
6.10.3 Wellue Next-Generation Wearable Holter Device Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Wellue Next-Generation Wearable Holter Device Product Portfolio
6.10.5 Wellue Recent Developments/Updates
6.11 Bardy Diagnostics
6.11.1 Bardy Diagnostics Corporation Information
6.11.2 Bardy Diagnostics Next-Generation Wearable Holter Device Description and Business Overview
6.11.3 Bardy Diagnostics Next-Generation Wearable Holter Device Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Bardy Diagnostics Next-Generation Wearable Holter Device Product Portfolio
6.11.5 Bardy Diagnostics Recent Developments/Updates
6.12 Coala Life
6.12.1 Coala Life Corporation Information
6.12.2 Coala Life Next-Generation Wearable Holter Device Description and Business Overview
6.12.3 Coala Life Next-Generation Wearable Holter Device Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Coala Life Next-Generation Wearable Holter Device Product Portfolio
6.12.5 Coala Life Recent Developments/Updates
6.13 ScottCare
6.13.1 ScottCare Corporation Information
6.13.2 ScottCare Next-Generation Wearable Holter Device Description and Business Overview
6.13.3 ScottCare Next-Generation Wearable Holter Device Sales, Revenue and Gross Margin (2018-2023)
6.13.4 ScottCare Next-Generation Wearable Holter Device Product Portfolio
6.13.5 ScottCare Recent Developments/Updates
6.14 Biotricity
6.14.1 Biotricity Corporation Information
6.14.2 Biotricity Next-Generation Wearable Holter Device Description and Business Overview
6.14.3 Biotricity Next-Generation Wearable Holter Device Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Biotricity Next-Generation Wearable Holter Device Product Portfolio
6.14.5 Biotricity Recent Developments/Updates
6.15 Cardiac Insight
6.15.1 Cardiac Insight Corporation Information
6.15.2 Cardiac Insight Next-Generation Wearable Holter Device Description and Business Overview
6.15.3 Cardiac Insight Next-Generation Wearable Holter Device Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Cardiac Insight Next-Generation Wearable Holter Device Product Portfolio
6.15.5 Cardiac Insight Recent Developments/Updates
6.16 Icentia Inc
6.16.1 Icentia Inc Corporation Information
6.16.2 Icentia Inc Next-Generation Wearable Holter Device Description and Business Overview
6.16.3 Icentia Inc Next-Generation Wearable Holter Device Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Icentia Inc Next-Generation Wearable Holter Device Product Portfolio
6.16.5 Icentia Inc Recent Developments/Updates
6.17 Ranealth
6.17.1 Ranealth Corporation Information
6.17.2 Ranealth Next-Generation Wearable Holter Device Description and Business Overview
6.17.3 Ranealth Next-Generation Wearable Holter Device Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Ranealth Next-Generation Wearable Holter Device Product Portfolio
6.17.5 Ranealth Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Next-Generation Wearable Holter Device Industry Chain Analysis
7.2 Next-Generation Wearable Holter Device Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Next-Generation Wearable Holter Device Production Mode & Process
7.4 Next-Generation Wearable Holter Device Sales and Marketing
7.4.1 Next-Generation Wearable Holter Device Sales Channels
7.4.2 Next-Generation Wearable Holter Device Distributors
7.5 Next-Generation Wearable Holter Device Customers
8 Next-Generation Wearable Holter Device Market Dynamics
8.1 Next-Generation Wearable Holter Device Industry Trends
8.2 Next-Generation Wearable Holter Device Market Drivers
8.3 Next-Generation Wearable Holter Device Market Challenges
8.4 Next-Generation Wearable Holter Device Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
